LIFECORE BIOMEDICAL, INC. Payments to Acquire Additional Interest in Subsidiaries
LIFECORE BIOMEDICAL, INC. (LFCR) reported Payments to Acquire Additional Interest in Subsidiaries of $15.00 million for the 12-month period ending 2011-05-29, per its 10-K filed 2012-08-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries · last filed 2012-08-08
- LIFECORE BIOMEDICAL, INC. payments to acquire additional interest in subsidiaries for the quarter ending 2011-05-29 was $0.00.
- LIFECORE BIOMEDICAL, INC. payments to acquire additional interest in subsidiaries for fiscal 2011 was $15.00M.
| Period end | Payments to Acquire Additional Interest in Subsidiaries 3 month | Payments to Acquire Additional Interest in Subsidiaries 9 month | Payments to Acquire Additional Interest in Subsidiaries 12 month |
|---|---|---|---|
| 2011-05-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-08 | $15.00M 10-K · filed 2012-08-08 | |
| 2011-02-27 | $15.00M 10-Q · filed 2012-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |